ISPOR Europe 2025
9 - 12 November
-
From Evidence to Excel: Generative AI for Automated SLR Data Extractions
Sep 9, 2025, 16:22 PM -
Primary Lateral Sclerosis (PLS): A Targeted Literature Review of Symptoms, Progression, and Outcomes to Inform Evidence Gaps for Rare Neurological Disorders
Sep 9, 2025, 16:22 PM -
Rare Disease Awareness Among Physicians in Five European Countries: Results of a Cross-Sectional Survey
Sep 9, 2025, 16:22 PM -
An Analysis of Differences in Patient Access to CGRP Migraine Treatments in the Nordic Region
Sep 9, 2025, 16:22 PM -
Routing Decisions and Outcomes of NICE Technology Appraisals Underproportionate Approach to Technology Appraisals
Sep 9, 2025, 16:22 PM -
The New Discount on Combination Drug Therapies in Germany: First Numbers and Assessment From a Payor Perspective
Sep 9, 2025, 16:22 PM -
Win Ratio in the Presence of Censored Data: Can Probabilistic Variants Improve Robustness?
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness and Budget Impact Analysis of Noninvasive Prenatal Testing (NIPT) for the Identification of Fetal Chromosomal Aneuploidies in Brazilian Private Healthcare System
Sep 9, 2025, 16:22 PM -
Expanded Access to Oncology Therapies in Mexico: The Role of Bioequivalent Abiraterone and Axitinib
Sep 9, 2025, 16:22 PM -
Investigation of Patient Satisfaction With Home Nursing Care Among Recipients
Sep 9, 2025, 16:22 PM -
Quantifying the Value of Information in Early Stage Health Technology Assessment: Guiding Investment in Evidence Generation
Sep 9, 2025, 16:22 PM -
Does Proposed IRP Introduction in the US Align With Current IRP Trends and With Best Practice Guidelines?
Sep 9, 2025, 16:22 PM -
Association Between ALK Tyrosine Kinase Inhibitor and the Risk of Interstitial Lung Disease and Pneumonitis in Non-Small Cell Lung Cancer Patients: A Systematic Review
Sep 9, 2025, 16:22 PM -
Simulating PICOs to Predict Evidence Requirement Implications of the EU Joint Clinical Assessment: Learnings From 24 Case Studies
Sep 9, 2025, 16:22 PM -
Quality of Life of Patients Living With Epilepsy in Hungary
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Modifying Cardiovascular Disease Risk Factors in Qatar Using the Productivity-Adjusted Life Years (PALY) Metric
Sep 9, 2025, 16:22 PM -
Healthcare Resource Use and Mortality After Diabetic Ketoacidosis: Insights From Linked Primary- and Secondary-Care Data in the UK
Sep 9, 2025, 16:22 PM -
Health Economic Evaluations of Prevention and Management Strategies for Cholangiocarcinoma: A Systematic Review
Sep 9, 2025, 16:22 PM -
Assessing the Value of Purewick™ System for the Management of Female Patients With Urinary Incontinence in the Nonacute Setting: Preliminary Cost-Effectiveness Analysis
Sep 9, 2025, 16:22 PM -
Real-World Cancer Treatments for Common Solid Tumors in China: A Targeted Literature Review
Sep 9, 2025, 16:22 PM